Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials

Por Goffin John R, Pond Greg R
Publicado em 2011-12-01

Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials

Por Goffin, John R, Pond, Greg R
Publicado em 2011

A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials

Por Tu Dongsheng, Pond Greg R, Goffin John R
Publicado em 2011-06-01

A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials

Por Goffin, John R, Pond, Greg R, Tu, Dongsheng
Publicado em 2011

Perspective on the National Comprehensive Cancer Network’s (NCCN) Clinical Practice Guidelines for Smoking Cessation

Por Ostroff, Jamie S., Goffin, John R., Khuri, Fadlo R., Warren, Graham W.
Publicado no J Oncol Pract (2015)

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Por Robson, Mark E, Chappuis, Pierre O, Satagopan, Jaya, Wong, Nora, Boyd, Jeff, Goffin, John R, Hudis, Clifford, Roberge, David, Norton, Larry, Bégin, Louis R, Offit, Kenneth, Foulkes, William D
Publicado em 2004